Endocrine treatment of prostatic cancer |
| |
| Authors: | Jeffrey J. Pollen |
| |
| Affiliation: | From the Division of Urology, Department of Surgery, University of California Medical Center, and the Urology Section, Veterans Administration Medical Center, San Diego, California, USA |
| |
| Abstract: | Data are drawn from the pertinent literature supporting diethylstilbestrol for initial endocrine treatment of advanced prostatic cancer. When diethylstilbestrol is given in a dosage of 2 mg daily, the risk of cardiovascular complications is low. Bilateral orchiectomy is reserved for high-risk patients or those intolerant of estrogen. To prevent possible complications of uncontrolled tumor growth and perhaps to increase survival time, endocrine treatment of advanced prostatic cancer should be started early. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
